News on ANTISENSE PHARMA GmbH from BioPortfolio.com http://www.BioPortfolio.com Consolidated ANTISENSE PHARMA GmbH news from BioPortfolio.com Wed, 10 Feb 2010 05:51:43 GMT en Kamada Announces Enrollment Of First Patient In Its Pivotal Study For Inhaled AAT In Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039685&HITNO=0&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039685&THISHREF=http://c.moreover.com/click/here.pl%3fz2538321789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039685&HITNO=0&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039685&THISHREF=http://c.moreover.com/click/here.pl%3fz2538321789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Daiichi Sankyo's subsidiary seeks approval for Alzheimer's type Dementia treatment in Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039734&HITNO=1&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039734&THISHREF=http://c.moreover.com/click/here.pl%3fz2538348937%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039734&HITNO=1&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039734&THISHREF=http://c.moreover.com/click/here.pl%3fz2538348937%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Antisense Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037053&HITNO=2&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037053&THISHREF=http://c.moreover.com/click/here.pl%3fz2536880950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037053&HITNO=2&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037053&THISHREF=http://c.moreover.com/click/here.pl%3fz2536880950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: ALIUD Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037799&HITNO=3&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037799&THISHREF=http://c.moreover.com/click/here.pl%3fz2537289098%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037799&HITNO=3&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037799&THISHREF=http://c.moreover.com/click/here.pl%3fz2537289098%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037052&HITNO=4&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037052&THISHREF=http://c.moreover.com/click/here.pl%3fz2536879771%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037052&HITNO=4&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037052&THISHREF=http://c.moreover.com/click/here.pl%3fz2536879771%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: CellAct Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033999&HITNO=5&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033999&THISHREF=http://c.moreover.com/click/here.pl%3fz2535548161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033999&HITNO=5&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033999&THISHREF=http://c.moreover.com/click/here.pl%3fz2535548161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032207&HITNO=6&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032207&THISHREF=http://c.moreover.com/click/here.pl%3fz2534545101%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032207&HITNO=6&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032207&THISHREF=http://c.moreover.com/click/here.pl%3fz2534545101%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: SuppreMol appoints Dr. Robert Phelps as Head of Business Development & Licensinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033095&HITNO=7&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033095&THISHREF=http://c.moreover.com/click/here.pl%3fz2535006984%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033095&HITNO=7&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033095&THISHREF=http://c.moreover.com/click/here.pl%3fz2535006984%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Gastroenterology: Report summarizes gastroenterology study findings from Novartishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033355&HITNO=8&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033355&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033355&HITNO=8&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033355&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Kamada commences enrollment in European inhaled AAT clinical trial for alpha-1 antitrypsin deficiencyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033287&HITNO=9&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033287&THISHREF=http://c.moreover.com/click/here.pl%3fz2535101033%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033287&HITNO=9&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033287&THISHREF=http://c.moreover.com/click/here.pl%3fz2535101033%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Croma Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031481&HITNO=10&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031481&THISHREF=http://c.moreover.com/click/here.pl%3fz2534225800%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031481&HITNO=10&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031481&THISHREF=http://c.moreover.com/click/here.pl%3fz2534225800%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Merz Pharma GmbH & Co. KGaA-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027310&HITNO=11&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027310&THISHREF=http://c.moreover.com/click/here.pl%3fz2532036743%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027310&HITNO=11&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027310&THISHREF=http://c.moreover.com/click/here.pl%3fz2532036743%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Dr. Ritsert Pharma GmbH & Co KG-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030727&HITNO=12&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030727&THISHREF=http://c.moreover.com/click/here.pl%3fz2533795479%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030727&HITNO=12&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030727&THISHREF=http://c.moreover.com/click/here.pl%3fz2533795479%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: MIKA Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027269&HITNO=13&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027269&THISHREF=http://c.moreover.com/click/here.pl%3fz2532002049%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027269&HITNO=13&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027269&THISHREF=http://c.moreover.com/click/here.pl%3fz2532002049%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Dr. Falk Pharma GmbH-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030655&HITNO=14&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030655&THISHREF=http://c.moreover.com/click/here.pl%3fz2533748244%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030655&HITNO=14&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ANTISENSE%20PHARMA%20GmbH&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030655&THISHREF=http://c.moreover.com/click/here.pl%3fz2533748244%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: